Michael J. Fox Foundation awards Casma Therapeutics grant to advance PD drug development May 30, 2019
Gut-derived live bacterial strains found to modulate neuroinflammation and neurodegeneration in PD May 30, 2019
Zynerba initiates phase II trial of Zygel to treat behavioral symptoms in 22q11.2 deletion syndrome May 29, 2019
ProMIS identifies antibody candidates that selectively bind toxic oligomers of tau for Alzheimer's May 29, 2019
RSS